QSA's Week in BioPharma (#15, 2025)

Revocation of charity registration; Genomics research in B.C.; Manitoba's COVID-19 vaccination plan; New DNA cutting tool; Two new research chairs in Quebec.

QSA's Week in BioPharma (#15, 2025)

Good morning! Welcome back to Queen Street Analytics' weekly roundup of regulatory developments, legislative discussions, political announcements and other government-related news in biotech, pharmaceutical manufacturing, drug distribution and pricing, the life sciences and medical research.

Every Monday, we break down the most important updates in this space in under five minutes.

Looking to elevate your organization’s presence or streamline your approach to government relations with more data-driven solutions? Queen Street Analytics is here to help you achieve your goals: faster, smarter, and more effectively. Let’s start the conversation. Reach us at contact@queenstreetanalytics.com to learn how we can support your success.


Start Date: 2025-04-13
End Date: 2025-04-19

Top Headlines

Main Stories

Genomics Research to Enhance Patient Care in B.C.

British Columbia is advancing patient care through eight new genomics research projects, in collaboration with Genome BC and Genome Alberta, focusing on cancer, heart disease, and infections.

Sources: Provincial Announcement: news.gov.bc.ca

Institut National de la Recherche Scientifique Develops New DNA Tool

A team at INRS in Montreal has discovered a new enzyme family capable of targeted cuts in single-stranded DNA, potentially revolutionizing genetic manipulation techniques.

Sources: Provincial Announcement: www.quebec.ca

New Research Chairs in Microbiology in Quebec

INRS announces two new Canada Research Chairs focusing on microbial interactions, supported by $2.8 million in funding, aimed at developing innovative treatments and sustainable agriculture.

Sources: Provincial Announcement: www.quebec.ca